Davita Inc vs State Street SPDR S&P Homebuilders ETF — how do they compare? Davita Inc trades at $175.04 (market cap $11.29B), while State Street SPDR S&P Homebuilders ETF trades at $95.99 (market cap $1.49B). The key difference: Davita Inc is far larger — about 7.6× State Street SPDR S&P Homebuilders ETF's market cap, and Davita Inc is trading nearer its 52-week high, State Street SPDR S&P Homebuilders ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and State Street SPDR S&P Homebuilders ETF for 33 Days on average.
| DVA | XHB | |
|---|---|---|
Market Cap | $11.29B | $1.49B |
Volume | 582,204 | 2,445,587 |
Sector | Health | Broad Market / Factor |
52-Week High | $240.96 | $121.36 |
52-Week Low | $103.87 | $94.86 |
Typical Hold Time | 113 Days | 33 Days |
Enterprise Value | $24.01B | — |
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $176.78, down 2.01% today, showing technical bearish signals with price near key support at $175. Fundamentally, the company demonstrates solid earnings performance with three consecutive quarterly beats and attractive valuation metrics including a P/E of 14.98 and P/S of 0.88. Recent expansion of value-based care partnerships with Humana positions the company for continued growth in kidney care services.
The stock presents a compelling value opportunity with analyst consensus target of $235.67 offering 33% upside potential, though investors face risks from regulatory pressures and narrowing profit margins. Warren Buffett's significant ownership (45%) and institutional buying activity provide confidence, but the bearish technical outlook and mixed analyst ratings (43% Buy, 52% Hold) suggest cautious optimism is warranted.
XHB (SPDR S&P Homebuilders ETF) trades at $94.89, down 2.55% amid broader housing sector pressure from rising mortgage rates. Technical indicators show bearish momentum with moving averages signaling sell pressure, though RSI suggests potential oversold conditions. Recent news highlights institutional interest with Greenland Capital's $17.33 million investment, while new housing legislation and mixed home sales data create uncertainty. The ETF's valuation metrics remain undisclosed in current data.
The housing ETF faces headwinds from 7% mortgage rates but benefits from structural demand and policy support. Near-term performance hinges on interest rate trends and housing market data, with current technical weakness offering potential entry points for long-term housing recovery bets. Key risks include prolonged high rates and economic slowdown impacting buyer affordability.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →XHB invests in the U.S. homebuilding industry and related sectors. It provides equal-weighted exposure to homebuilders, building products, and home improvement retailers like Home Depot, Lowe's, and Builders FirstSource.
Read more on XHB →